This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (47) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Brucker, P. S. Articles by Cella, D. Search for Related Content PubMed PubMed Citation Articles by Brucker, P. S. Articles by Cella, D. Pubmed/NCBI databases Medline Plus Health Information Cancer Cancer--Living with Cancer Social Bookmarking                         What's this?

General Population and Cancer Patient Norms for the Functional Assessment of Cancer Therapy-General (FACT-G)

Feinberg School of Medicine at Northwestern University, p-brucker{at}northwestern.edu

Kathleen Yost

Center on Outcomes Research and Education (CORE) at Evanston Northwestern Healthcare, Feinberg School of Medicine at Northwestern University

John Cashy

Center on Outcomes Research and Education (CORE) at Evanston Northwestern Healthcare, Feinberg School of Medicine at Northwestern University

Kimberly Webster

Center on Outcomes Research and Education (CORE) at Evanston Northwestern Healthcare, Feinberg School of Medicine at Northwestern University

David Cella

Center on Outcomes Research and Education (CORE) at Evanston Northwestern Healthcare, Feinberg School of Medicine at Northwestern University

Given the number of new cancer cases diagnosed each year and the increases in survival rates, the importance of having a clinically useful health-related quality of life (HRQOL) instrument has increased. The Functional Assessment of Cancer Therapy-General (FACT-G) is one such instrument that has been used worldwide to assess HRQOL. Previously, the use of the FACT-G had been limited because of a lack of published normative data. Normative data are useful for consumers to place their results in an appropriate context by comparing their scores of individuals or group of individuals to a reference group. Here, we present normative data for the FACT-G for two reference groups: (a) a sample of the general U.S. adult population and (b) a large, heterogeneous sample of adult patients with cancer. In addition, we demonstrate various uses of the normative data.

Key Words: quality of life • reference values • cancer • normative data

Evaluation & the Health Professions, Vol. 28, No. 2, 192-211 (2005)
DOI: 10.1177/0163278705275341


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. B. Kornblith, H. Q. Huang, J. L. Walker, N. M. Spirtos, J. Rotmensch, and D. Cella Quality of Life of Patients With Endometrial Cancer Undergoing Laparoscopic International Federation of Gynecology and Obstetrics Staging Compared With Laparotomy: A Gynecologic Oncology Group Study J. Clin. Oncol., November 10, 2009; 27(32): 5337 - 5342. [Abstract] [Full Text] [PDF]

				N. Reavley, J. F. Pallant, and A. Sali Evaluation of the Effects of a Psychosocial Intervention on Mood, Coping, and Quality Of Life in Cancer Patients Integr Cancer Ther, March 1, 2009; 8(1): 47 - 55. [Abstract] [PDF]

				J.-x. Cheng, X. Zhang, and B.-L. Liu Health-related quality of life in patients with high-grade glioma Neuro-oncol, January 1, 2009; 11(1): 41 - 50. [Abstract] [Full Text] [PDF]

				C. A. Espie, L. Fleming, J. Cassidy, L. Samuel, L. M. Taylor, C. A. White, N. J. Douglas, H. M. Engleman, H.-L. Kelly, and J. Paul Randomized Controlled Clinical Effectiveness Trial of Cognitive Behavior Therapy Compared With Treatment As Usual for Persistent Insomnia in Patients With Cancer J. Clin. Oncol., October 1, 2008; 26(28): 4651 - 4658. [Abstract] [Full Text] [PDF]

				D. Cella, J. Z. Li, J. C. Cappelleri, A. Bushmakin, C. Charbonneau, S. T. Kim, I. Chen, and R. J. Motzer Quality of Life in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib or Interferon Alfa: Results From a Phase III Randomized Trial J. Clin. Oncol., August 1, 2008; 26(22): 3763 - 3769. [Abstract] [Full Text] [PDF]

				A. B. Moadel, C. Shah, J. Wylie-Rosett, M. S. Harris, S. R. Patel, C. B. Hall, and J. A. Sparano Randomized Controlled Trial of Yoga Among a Multiethnic Sample of Breast Cancer Patients: Effects on Quality of Life J. Clin. Oncol., October 1, 2007; 25(28): 4387 - 4395. [Abstract] [Full Text] [PDF]

				R. J. Motzer, T. E. Hutson, P. Tomczak, M. D. Michaelson, R. M. Bukowski, O. Rixe, S. Oudard, S. Negrier, C. Szczylik, S. T. Kim, et al. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma N. Engl. J. Med., January 11, 2007; 356(2): 115 - 124. [Abstract] [Full Text] [PDF]